Registered outcomes29

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

21 to 29 of 29

List	Outcome	Time frame	Description
Secondary	In participants receiving placebo IV in the DBTP, the extent of disease control, defined as the number of cumulative weeks with platelet counts of at least 50 × 10^9/L during the first 24 weeks of treatment with efgartigimod IV	Up to 24 weeks
Secondary	Occurrence rate of rescue ITP therapy	Up to 76 weeks
Secondary	Proportion of participants with reduction in concurrent ITP therapy during the OLTP1	Up to 52 weeks
Secondary	Incidence and severity of bleeding, assessed by the ITP Bleeding Scale (IBLS)	Up to 76 weeks
Secondary	Incidence of AEs (including AEs of clinical interest) and SAEs	Up to 136 weeks	AE = adverse event; SAE = serious adverse event; An adverse event of clinical interest is a pre-specified medically significant event that has the potential to be causally associated with the study drug.
Secondary	Incidence of ADA against efgartigimod in serum over time	Up to 136 weeks	ADA = antidrug antibodies
Secondary	Incidence of NAb against efgartigimod in serum over time	Up to 136 weeks	NAb = Neutralizing antibodies
Secondary	Efgartigimod Cmax over time	Up to 136 weeks
Secondary	Percent change from baseline in total IgG levels in serum over time	Up to 136 weeks	IgG = immunoglobulin G

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNone stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT06544499/registered?page=2